Lecrolyn

Sodium cromoglicate, the active ingredient in Lecrolyn, is a mast cell stabilizer presented as eye drops for ocular use. It is used to manage allergic conjunctivitis, vernal keratoconjunctivitis, and other mast cell‑mediated inflammatory conditions of the eye.

GNH USA supplies Lecrolyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Our distribution network ensures reliable delivery across Europe, Asia, Africa and the Americas.

Lecrolyn, a mast cell stabilizer, is indicated for ocular allergic conditions that involve mast cell activation. - Allergic conjunctivitis: reduces ocular itching, redness and tearing by preventing mast cell degranulation. - Vernal keratoconjunctivitis: helps control chronic inflammation and photophobia in seasonal allergic eye disease. - Mast cell‑mediated ocular inflammatory conditions: provides symptomatic relief in other eye disorders driven by mast cell release.

Topical ocular administration of Lecrolyn may be associated with local and, rarely, systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation upon instillation. - Temporary blurred vision. - Mild eye irritation or redness. - Tearing or watery discharge.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) affecting the eye or systemic. - Persistent ocular inflammation or worsening of symptoms. - Corneal ulceration. - Vision loss.

When prescribing Lecrolyn, clinicians should consider the following precautions to ensure safe and effective use. - Contraindication: avoid use in patients with known hypersensitivity to sodium cromoglicate or any formulation components. - Contact lens wear: discontinue use while wearing contact lenses and wait at least 15 minutes before reinserting. - Pregnancy and lactation: safety has not been established; use only if potential benefit outweighs risk. - Pediatric use: dosage and frequency should be determined by an ophthalmologist experienced in pediatric care. - Systemic absorption: monitor for signs of systemic allergic reactions despite low systemic exposure. - Store at room temperature: keep the bottle in the original packaging, protect from light and moisture, and do not freeze.

Lecrolyn may interact with other ophthalmic agents or systemic medications that affect mast cell function or ocular surface integrity.

Major Interactions (Avoid): - Concurrent use of topical antihistamine or mast cell stabilizer containing preservatives that may increase ocular irritation. - Systemic immunosuppressants that could mask signs of ocular infection.

Moderate Interactions (Monitor Closely): - Other eye drops (e.g., corticosteroids, non‑steroidal anti‑inflammatory drugs) administered within a short interval; stagger dosing to reduce washout. - Contact lens solutions containing preservatives that may exacerbate irritation. - Systemic antihistamines that may reduce tear production, potentially increasing discomfort.